Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 7.26
(0.55%)
CNY 7.26
(0.55%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 169.33 Million CNY | 41.4% |
| 2022 | 197.28 Million CNY | -3.68% |
| 2021 | 204.81 Million CNY | 15.59% |
| 2020 | 177.18 Million CNY | -7.67% |
| 2019 | 191.91 Million CNY | -72.01% |
| 2018 | 685.6 Million CNY | 4.6% |
| 2017 | 655.47 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 50.28 Million CNY | -28.38% |
| 2024 Q2 | 45.48 Million CNY | -9.54% |
| 2024 Q3 | 45.96 Million CNY | -0.7% |
| 2023 Q1 | 43.02 Million CNY | -5.73% |
| 2023 FY | 278.96 Million CNY | 41.4% |
| 2023 Q4 | 70.2 Million CNY | 44.54% |
| 2023 Q3 | 48.57 Million CNY | 2.94% |
| 2023 Q2 | 47.18 Million CNY | 9.65% |
| 2022 Q3 | 51.07 Million CNY | 4.18% |
| 2022 Q2 | 49.02 Million CNY | -4.88% |
| 2022 Q1 | 51.54 Million CNY | 1.15% |
| 2022 FY | 197.28 Million CNY | -3.68% |
| 2022 Q4 | 45.64 Million CNY | -10.62% |
| 2021 Q2 | 56.76 Million CNY | 19.0% |
| 2021 Q1 | 47.7 Million CNY | 20.96% |
| 2021 FY | 204.81 Million CNY | 15.59% |
| 2021 Q4 | 50.95 Million CNY | 3.15% |
| 2021 Q3 | 49.39 Million CNY | -12.98% |
| 2020 Q1 | 29.46 Million CNY | -18.04% |
| 2020 FY | 177.18 Million CNY | -7.67% |
| 2020 Q4 | 39.43 Million CNY | 142.73% |
| 2020 Q3 | -92.29 Million CNY | -319.53% |
| 2020 Q2 | 42.04 Million CNY | 42.67% |
| 2019 Q3 | -81.96 Million CNY | 0.0% |
| 2019 Q4 | 35.95 Million CNY | 143.86% |
| 2019 FY | 191.91 Million CNY | -72.01% |
| 2018 FY | 685.6 Million CNY | 4.6% |
| 2017 FY | 655.47 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.78 Billion CNY | 90.513% |
| Joinn Laboratories(China)Co.,Ltd. | 505.68 Million CNY | 66.515% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 96.427% |
| Autobio Diagnostics Co., Ltd. | 1.52 Billion CNY | 88.901% |
| Thalys Medical Technology Group Inc. | 570.05 Million CNY | 70.296% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 2.35 Billion CNY | 92.811% |